Recent Progress in Health Benefits from Curcumin

Dear Colleagues,

Natural products have been used in medicine for thousands of years; in recent times, they have gained significant attention globally due to their potential health benefits.

Polyphenols such as resveratrol, curcumin and flavonoids etc. are involved in the plant’s defensive response against stress from ultraviolet radiation, pathogens and physical damage. Phytochemicals regulate differential gene expression to modulate various cellular pathways implicated in cellular protection. Curcumin, a natural dietary polyphenol extracted from Curcuma Longa L., is an anti-inflammatory, cyto- and DNA-protective, anti-diabetic, anti-cancer and anti-aging dietary compound.

Curcumin is a highly pleiotropic molecule that interacts with numerous molecular targets; in fact, different studies have demonstrated its capacity to attenuate the inflammatory response, induce the antioxidant pathway and exert anti-cancer effects. Curcumin’s bioavailability is very low in humans, so an appropriate drug delivery system is useful for its clinical application.

This Special Issue entitled “Recent Progress in Health Benefits from Curcumin” welcomes the submission of both original research manuscripts and reviews concerning the biological properties of curcumin in vitro and in clinical trials, its bioavailability and its health-promoting effects other than its potential therapeutic applications, including its incorporation into novel functional matrices.

Prof. Dr. Chiara Porro
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.